为您找到相关结果约500个

你是不是要搜索 期刊HER2 Exon20插入突變的非小細胞肺癌 点击跳转

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor

Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and responses in NSCLC HER2 exon 20

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions

Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC

Clinical outcomes for EGFR/HER2 exon 20 insertion-mutated NSCLC

EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib

TY-4028: a novel, targeted therapy for non small-cell lung cancer with EGFR exon 20 or HER2 exon 20 insertion

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven

Development of treatment for HER2 or EGFR exon 20 insertion mutation-driven NSCLC

Conformational Landscapes of HER2 Exon 20 Insertions Explain Their Sensitivity to Kinase Inhibitors in

HER2(+) mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy

Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis andSensitivity to HER2-Targeted Tyrosine Kinase Inhibitors

为您找到相关结果约500个

共500条页码: 1/34页15条/页